Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 YearsJeff D. Williamson, Nicholas M. Pajewski, William E. Haley et al.|JAMA|2016Cited by 1.2k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysisKazem Rahimi, Barry R. Davis, Takayoshi Ohkubo et al.|The Lancet|2021Cited by 997
Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.Stephen S. Gottlieb, M. Dekock, Kenneth Dickstein et al.|Circulation|1993Cited by 292